SynthesisDigestive diseases and sciences2024

Reactive Immunomodulator Addition to Infliximab Monotherapy Restores Clinical Response in Inflammatory Bowel Disease: A Meta-Analysis.

Jeffrey A Lowell et al.PubMed ↗Publisher ↗

No numbers read from the abstract.